Euphyllin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Euphyllin

Quick Facts

Property Description
Active ingredient Choline Theophyllinate
Form Tablets, Sustained-release tablets, Suppositories, Oral solution, Injectable solution
Pharmacological class Bronchodilator (Xanthine Derivative)
Common use Relief of bronchial obstruction
Origin Synthetic
Type Single-ingredient product

Euphyllin: Definition and Pharmacological Classification

Euphyllin is a synthetic single-ingredient pharmaceutical preparation whose active substance is Choline Theophyllinate, a compound clinically recognized for its systemic role in respiratory care. Chemically, it is classified as a Xanthine derivative and is recognized as a systemic drug for obstructive airway diseases. This active substance is a salt formed by combining the core bronchodilator Theophylline with Choline. The integration of Choline differentiates it from simple Theophylline, with the structure often designed to enhance overall solubility and improve the general patient tolerance profile.

Forms of Choline Theophyllinate and General Purpose

The medicine is broadly classified as a bronchodilator and spasmolytic agent, meaning it acts to relax the muscle tissue. Choline Theophyllinate is manufactured in several pharmaceutical preparations, including tablets (standard and sustained-release tablets), oral solution, suppositories, and an injectable solution provided in ampoules. The overarching general purpose of this medicine is directly related to its ability to relax the smooth muscles surrounding the bronchi. This action facilitates bronchodilation, which is the physical widening of the airways, thereby promoting easier air flow and counteracting the tightness associated with bronchial obstruction. The availability of multiple forms ensures the compound can be delivered through various routes, supporting its role as a tool for managing chronic airway muscle constriction.

What side effects are possible with Euphyllin?

The official safety profile for Choline Theophyllinate (the active core of Euphyllin) emphasizes that the risk of adverse reactions is highly concentration-dependent, meaning the severity and frequency of effects are linked to the amount of substance in the bloodstream, a factor explicitly monitored by regulators.

Documented Adverse Reactions

Adverse reactions are classified in regulatory documents across several physiological systems. Common non-serious effects frequently listed include nausea, vomiting, diarrhea, headache, insomnia, and restlessness. These less severe reactions are often transient, especially upon the start of therapy.

System-Organ Class Key Adverse Reactions (Regulatory Focus)
Gastrointestinal Nausea, Vomiting, Diarrhea, Abdominal discomfort
Nervous System Headache, Dizziness, Tremors, Seizures
Cardiac Disorders Tachycardia (fast heartbeat), Ventricular arrhythmias

Serious Safety Considerations

The most critical adverse events documented in official labels are potentially fatal seizures and life-threatening ventricular arrhythmias (irregular heartbeats), particularly when drug concentrations exceed the recommended therapeutic range. Severe toxicity may also be indicated by persistent vomiting or profound hypotension.

Population and Exposure Constraints

Regulatory documentation mandates specific safety considerations for patient groups with altered drug clearance. Older adults and individuals with hepatic impairment (e.g., cirrhosis) are identified as having a significantly increased risk of serious toxicity due to reduced metabolism of the compound. The medicine is contraindicated in individuals with known hypersensitivity to Xanthine derivatives and requires extreme caution in those with pre-existing seizure disorders.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

Overdose with Euphyllin (Choline Theophyllinate) is formally documented to involve a progression of severe symptoms affecting multiple physiological systems. Initial manifestations often include gastrointestinal distress such as nausea, severe vomiting, and abdominal pain, along with central nervous system (CNS) effects like tremor, agitation, and restlessness.


Severe Manifestations and Required Action

The official prescribing information highlights the risk of life-threatening outcomes, including generalized seizures and serious ventricular arrhythmias leading to cardiac arrest and death. These severe manifestations require that immediate medical attention must be sought. Due to the systemic risks, professional emergency care is mandated for any significant clinical deterioration.


Management and Monitoring Requirements

As no specific chemical antidote is known, the management protocol is strictly symptomatic and supportive. Regulatory documents require gastrointestinal decontamination, such as the administration of activated charcoal. For severe toxicity, procedures for enhanced elimination, notably haemodialysis, are officially documented. Continuous monitoring of serum theophylline concentrations, electrolytes, and cardiac rhythm via ECG is required during hospitalization. Overdose severity is noted to be increased in very young infants and elderly patients, and in those with pre-existing conditions that impair drug clearance, such as hepatic impairment or heart failure.

Therapeutic Uses of Euphyllin

What Euphyllin Treats: Main Uses and Benefits

This medication is commonly used to help with symptoms in conditions characterized by restricted airflow, such as bronchial asthma and Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema. The active substance, theophylline, is utilized to prevent and treat symptoms associated with these conditions. The goal is to provide sustained symptomatic support to manage the persistent nature of these diseases, and it may assist with easing the overall symptom burden, supporting patients during episodes of heightened discomfort.


Choline Theophyllinate is commonly used to help with symptoms related to the tightening of the airways. It is applied when groups of symptoms appear suddenly or fluctuate, such as chest tightness, wheezing, and shortness of breath linked to these physical manifestations. It is relevant for managing symptoms that create noticeable physiological strain. The symptomatic relief is relevant for patients, supporting them to cope more steadily with difficult episodes and assisting with maintaining functional stability when symptoms are more noticeable. Specialized uses also include supportive management for apnea of prematurity in infants and is relevant for easing symptoms related to post-dural puncture headache.


Quick Fact: Relief for Symptoms Related to Airway Constriction

Category Typical Use
Main Conditions Chronic Asthma, COPD, Chronic Bronchitis
Primary Symptoms Wheezing, Chest Tightness, Dyspnea
Therapeutic Role Supportive, Long-term Symptom Management
Patient Benefit Easing the overall symptom load

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Euphyllin is contraindicated in any individual with a documented hypersensitivity to xanthine derivatives, which includes theophylline. Some official regulatory labels also specify a contraindication for use in children under six months of age.

Eligibility is significantly restricted by age and underlying health conditions due to the drug's highly variable metabolism. Extreme caution is required when the medicine is used in infants under one year and in the elderly (ge 60 years) because both groups exhibit reduced metabolic clearance, increasing the risk of toxicity.

Use is also restricted for patients with compromised physiological states, including hepatic impairment (e.g., cirrhosis), Congestive Heart Failure (CHF), and acute febrile illness. Conditions such as active peptic ulcer disease and seizure disorders require caution, as documented by regulatory bodies.

In terms of reproductive status, the drug is classified as US FDA Pregnancy Category C. Use during pregnancy or lactation is restricted and permitted only when the documented benefit to the mother is determined to outweigh the potential risk to the fetus or nursing infant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Euphyllin (Choline Theophyllinate) is defined by pharmacokinetic changes that alter its clearance and specific pharmacodynamic effects, as documented by regulatory agencies.


Pharmacokinetic Clearance Alterations

The clearance of the active substance, theophylline, is formally documented to be affected by co-administered drugs and physiological factors.

Interaction Outcome Interacting Substances/Factors
Decrease Clearance (Increased Exposure) Cimetidine, Macrolide antibiotics (e.g., Erythromycin), Ciprofloxacin, Fluvoxamine, Zileuton
Increase Clearance (Decreased Exposure) Anticonvulsants (e.g., Phenytoin, Carbamazepine), Rifampicin, Smoking, St. John's Wort

Clearance is also reduced in specific populations, including elderly patients, neonates, and individuals with hepatic impairment or acute fever, a constraint recognized in official labeling.


Pharmacodynamic Effects and Restrictions

Specific pharmacodynamic interactions are noted in regulatory documents, such as the antagonism of co-administered Adenosine receptor agonists and the sedatory effects of Benzodiazepines.

Co-administration with Ephedrine is officially contraindicated in children under 6 years of age. Additionally, the concurrent use of beta2-adrenergic agonists, corticosteroids, or diuretics may potentiate the risk of hypokalaemia.

Mechanism of Action

The mechanism of action for Euphyllin (Theophylline) is defined by its ability to modulate two distinct cellular processes: enzyme activity and receptor signaling, which together influence smooth muscle function and innate inflammatory regulation.

The primary action is a non-selective competitive inhibition of Phosphodiesterase (PDE) enzymes (primarily PDE3 and PDE4) in airway smooth muscle. This inhibition prevents the breakdown of the cellular messenger cAMP, leading to its accumulation. The subsequent molecular cascade reduces calcium levels within the muscle cells, resulting in a reduction of contractile force in bronchial smooth muscle.

Theophylline also acts as a non-selective antagonist by blocking Adenosine Receptors. Since adenosine normally promotes muscle contraction and the release of inflammatory mediators, its blockade counteracts these signals. This receptor antagonism contributes to systemic stimulation and affects physiological processes that modulate airway reactivity, complementing the enzyme-inhibition effect.

Furthermore, the drug exerts a molecular anti-inflammatory effect by indirectly enhancing the function of Histone Deacetylase 2 (HDAC2), an enzyme involved in suppressing the transcription of pro-inflammatory genes. This offers a separate, concentration-dependent mechanism that suppresses the production of inflammatory mediators in the respiratory system.

Dosage and Administration Information

How Euphyllin is Used: Official Administration Guidelines

Euphyllin, which contains the active substance Choline Theophyllinate (Theophylline), is utilized in two primary administration contexts as outlined by regulatory guidelines. The oral route, involving tablets, capsules, or solutions, is the standard method for long-term maintenance therapy and symptom prevention. The intravenous (IV) route is reserved for short-term management of acute conditions and is typically administered in a supervised clinical setting.


Official Dosing and Frequency

Standard oral administration is based on fixed rules for initiation and maintenance. The typical adult starting dose ranges from 300 to 400 mg per day, administered as either a single dose or divided into two daily doses. The total daily dose for adults should generally not exceed 600 mg. Maintenance forms are most often scheduled for once-daily or twice-daily administration, and all doses should be taken at the same time each day to ensure consistent drug levels.


Administration Requirements and Adjustments

Official instructions include specific guidelines for preparation and intake. Extended-release tablets must be swallowed whole and must not be crushed, broken, or chewed. Dose calculation is often based on the patient's ideal body weight. Regulatory documents specify dosage limitations for certain patient populations, notably restricting the total daily dose for older adults to usually not more than 400 mg, while pediatric dosing is strictly determined by age and body weight. If a dose is forgotten, the official label suggests taking the missed dose as soon as it is remembered.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Euphyllin

Evidence for Use in Chronic Obstructive Pulmonary Disease (COPD)

Research examined the use of Choline Theophyllinate (Theophylline) for COPD and includes Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These studies primarily focus on adult populations with stable, chronic obstructive conditions. Research was associated with objective lung function tests, such as forced exhalation measures ( FEV1), and also monitored patient-reported outcomes related to physical discomfort. In these trials, findings described patterns of changes in lung function measurements when the medicine was compared to an inactive substance.

Studies also explored the use of this drug as an add-on therapy alongside modern inhaled medicines. The evidence regarding exacerbation outcomes was observed in some studies to be highly variable and heterogeneous. Long-term effects are not fully established regarding the sustained maintenance of lung function over many years, and data for certain groups remain insufficient.


Evidence for Use in Chronic Bronchial Asthma

Evidence for managing symptoms in chronic bronchial asthma stems from RCTs that was studied for both adults and children with conditions characterized by fluctuating or episodic manifestations. Researchers monitored objective measures like Peak Expiratory Flow Rate ( PEFR) and patient-reported outcomes describing perceived discomfort and the need for rescue inhalers. Studies report how symptoms evolved in the observed populations, describing patterns related to changes in lung function and changes in the requirement for rescue medication when compared to placebo.

Many trials exploring the use of this medicine for asthma have limited follow-up durations, providing limited data on the durability of the reported functional measurements. Comparative evidence that directly evaluates this medicine against certain modern inhaled therapies is often lacking or based on modest sample sizes.


Evidence for Specialized Use in Apnea of Prematurity

The research supporting this specialized use is often in the form of dedicated Randomized Trials focused exclusively on premature infants. Studies exploring short-term symptom changes examined the frequency and severity of apneic episodes, as well as the need for respiratory support. Research reports that the use of the medicine was associated with a lower frequency of observed apneic episodes in this population. The findings described patterns that were observed in some studies to be generally uniform, though limited information is available regarding long-term neurodevelopmental outcomes.

Frequently Asked Questions (FAQ)

Common questions about Euphyllin (FAQ)

Q: How quickly does Euphyllin start working after taking it?

A: Euphyllin's speed of action depends on the specific formulation. Official product information for prolonged-release forms indicates that peak concentrations in the bloodstream are typically reached after approximately five hours once a steady daily regimen has been established. The onset of the desired therapeutic effect can still vary for each individual.

Q: Does Euphyllin come in different forms, like tablets or liquid?

A: Yes, regulatory information confirms that the active substance, theophylline, is available in several forms to suit different needs. These documented forms include standard oral tablets, sustained-release tablets, oral solution (liquid), and a solution for injection typically reserved for use in a clinical setting.

Q: Is it normal to feel a bit jittery or restless after taking Euphyllin?

A: Official safety data lists restlessness and tremors as documented nervous system adverse effects. These effects are often dependent on the concentration of the medicine in the blood. Regulatory information indicates that these are documented nervous system adverse effects.

Q: Is it safe to drink coffee or caffeine while taking Euphyllin?

A: The medicine is in the same chemical class as caffeine (a Xanthine derivative). Regulatory warnings indicate that the use of caffeine-containing products may increase the potential for stimulating side effects and can potentially alter the clearance of the medicine. This is a point to be aware of during treatment.

Q: What is the typical duration of treatment with Euphyllin?

A: Euphyllin is officially indicated for the long-term maintenance treatment of chronic obstructive airway diseases. This means it is typically prescribed for extended periods to help control chronic symptoms. The specific length of time the medicine is needed is determined by the prescribing physician based on the individual's long-term management needs.

Q: Why does my doctor need to check my blood levels while I'm on Euphyllin?

A: Due to its narrow therapeutic range, official labeling emphasizes the importance of blood concentration monitoring. This monitoring is done to prevent the drug's levels from becoming too high, which increases the risk of serious adverse effects such as seizures or ventricular arrhythmias (irregular heartbeats).

Q: Are there any long-term side effects associated with Euphyllin use?

A: Official labels document potential serious events like seizures and arrhythmias, particularly when blood concentrations are high. The long-term safety profile focuses on these concentration-dependent effects. Data specifically detailing safety outcomes over many years of sustained use is often limited in regulatory summaries.

Q: Does Euphyllin interact with high blood pressure medications?

A: Yes, official drug interaction data notes that Euphyllin can interact with certain blood pressure medicines, specifically diuretics. Concurrent use may increase the risk of an electrolyte imbalance called hypokalaemia, where blood potassium levels are too low.

Q: Can Euphyllin affect my mood or cause anxiety?

A: While regulatory safety data does not explicitly use the term 'anxiety,' it does list other central nervous system effects such as restlessness, insomnia (difficulty sleeping), and tremors. These documented effects are often related to the stimulating properties of the medicine.

Q: Can Euphyllin be taken with food, or does it need to be taken on an empty stomach?

A: Regulatory instructions state that for sustained drug stability, the medicine should be taken consistently—either always with food or always on an empty stomach. This practice helps ensure stable and predictable drug levels in the bloodstream, which is important for effectiveness and safety.

Q: What is the purpose of the enteric coating on some Euphyllin tablets?

A: The purpose of special tablet coatings is generally to control how and where the medicine is released in the digestive system. For formulations like extended-release tablets, the coating helps slow absorption to maintain a therapeutic effect over many hours or to help reduce stomach irritation.

Q: Does Euphyllin interact with herbal supplements?

A: Regulatory information specifically notes that the herbal supplement St. John's Wort can interact with Euphyllin. This interaction can increase the rate at which the body clears the drug, potentially leading to lower blood levels and reduced effectiveness.

Q: Why are there concerns about drug interactions with Euphyllin?

A: Concerns exist because the clearance of theophylline is easily altered by many other substances. Since the medicine has a narrow therapeutic index (small margin between effectiveness and toxicity), any change in clearance can rapidly shift the blood level, increasing the risk of either ineffectiveness or serious toxicity.

Q: Can I drive or operate machinery while taking Euphyllin?

A: Official documents state that the medicine is generally expected to have no or negligible influence on the ability to drive or operate machinery. However, the label also lists nervous system effects like dizziness and tremors, which have the potential to affect performance.

Q: Is Euphyllin used only for breathing problems?

A: Euphyllin's primary approved uses are for conditions involving bronchial obstruction, such as asthma and COPD. Regulatory documents also confirm its use in a specific, specialized setting for treating apnea of prematurity (breathing pauses) in premature infants.

Q: What should I do if I miss a dose of Euphyllin?

A: Patient information indicates that if a dose is missed, it should be taken as soon as it is remembered. However, the official recommendation is to skip the missed dose if it is almost time for the next scheduled dose. This prevents the risk of taking too much medicine at one time.

Q: Can Euphyllin be used by children, and if so, what are the concerns?

A: Euphyllin (theophylline) is approved for use in children, with dosing strictly based on age and body weight, reflecting the need for precise control. Due to differences in metabolism, caution is warranted in infants and very young children because of an increased risk of toxicity.

Q: Are there different strengths or dosages of Euphyllin tablets?

A: Yes, official product information confirms that Euphyllin (theophylline) is supplied in multiple tablet strengths which vary based on the specific formulation. These different strengths are necessary to achieve the precise blood concentrations needed for efficacy and safety.

Q: How long does Euphyllin stay in the system?

A: The time it takes for the drug to clear the body varies greatly between individuals. However, for healthy adults who do not smoke, the mean elimination half-life is typically documented as being around 7 to 9 hours. This is the time required for half of the medicine to be cleared from the bloodstream.

Q: What are the signs that Euphyllin is working for my breathing?

A: Euphyllin works by helping to relax the smooth muscles in the airways, which leads to bronchodilation (airway widening). This mechanism is intended to relieve symptoms such as wheezing, coughing, and shortness of breath associated with chronic bronchial obstruction.

How should Euphyllin be stored and disposed of?

How to Store and Dispose of Euphyllin (Choline Theophyllinate)

Official labeling requires Euphyllin to be stored under specific conditions to maintain product stability.


Storage Requirements

  • Temperature: The medication must be kept at Controlled Room Temperature, typically between 20 C and 25 C (68 F and 77 F). Brief temperature excursions are generally allowed up to 30 C.
  • Protection: The container must be kept tightly closed and protected from light and moisture.
  • Child Safety: It is mandatory to store the medicine out of the sight and reach of children.
  • Handling: Unused portions of certain formulations, such as the injectable solution, must be discarded after use. Oral forms should be kept in the original container.

Disposal Instructions

To dispose of unused or expired Euphyllin, follow your local pharmacist's instructions or use an official drug take-back program. The medicine should not be flushed down the toilet or poured into a drain unless explicitly advised by a regulatory authority.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Euphyllin found in:

A-Z Index: